Ads
related to: drug relapse
Search results
CARsgen’s CAR T MM therapy shows early signs of efficacy in Phase I trial
Clinical Trials Arena via Yahoo Finance· 16 hours agoCT071 is CAR T cell drug that acts by binding to cells expressing GPRC5D. It was developed using...
Roche (RHHBY) Reports Upbeat Data on Columvi From STARGLO Study
Zacks via Yahoo Finance· 15 hours agoRoche's (RHHBY) Columvi significantly extends survival in patients with relapsed or refractory...
Three-Drug Regimen Shows OS Benefit in Third-Line DLBCL
MedPage Today· 1 day agoLoretta Nastoupil, MD, leads a discussion on the ECHELON-3 trial results
...Positive Results from Ongoing Clinical Trial of NX-5948 in Patients with Relapsed Refractory...
Benzinga· 2 days agoDr. Kim Linton, M.B.Ch.B, MRCP, Ph.D., FRCP, senior lecturer at the ...
What's Going On With Small-Cap Cancer Focused Nurix Therapeutics On Monday? - Nurix Therapeutics...
Benzinga· 13 hours agoNX-5948 is being evaluated in an ongoing Phase 1a/b trial in adults with relapsed or refractory...
Study demonstrates how AI can develop more personalized cancer treatment strategies
Medical Xpress· 9 hours agoOne of the greatest challenges in cancer treatment is maximizing the impact for the patient from drug treatments. Conventional treatment strategies, which focus on killing ...
Siemens Healthineers nets European approval for blood test to predict MS relapse risks
FierceBiotech· 14 hours agoSiemens Healthineers received European approval for a blood test designed to help predict the risk...
New data showcase promise, growing pains of CAR-T in autoimmune disease
BioPharma Dive via Yahoo Finance· 18 hours agoOne expert described trial results presented at EULAR last week as “unprecedented.” But reports of ...
Dr. Jeffrey Wheeler and Donnica Carpenter: Relapse amid recovery isn’t a failure. It’s a time to...
Indianapolis Business Journal· 4 days agoThe National Institute of Drug Abuse lays the facts out clearly: 40%-60% of people receiving...
Lantern Pharma secures Japan patent for cancer drug By Investing.com
Investing.com· 6 days ago:LTRN), a company leveraging artificial intelligence (AI) in cancer therapy development, has been...